Novavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023

Rhea-AI Summary

Novavax, Inc. will report its Q3 2023 financial results and operational highlights on November 9, 2023, at 8:30 a.m. EST. Conference call details and replay information are provided.

GAITHERSBURG, Md., Nov. 2, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its third quarter 2023 financial results and operational highlights at 8:30 a.m. Eastern Standard Time (EST) on Thursday, November 9, 2023. Details of the event and replay are as follows:

Conference call details:
Date:	November 9, 2023
Time:	8:30 a.m. U.S. EST
Dial-in number:	(877) 550-1858 (Domestic) or (848) 488-9160 (International)
Passcode:	1754341
Webcast:	ir.novavax.com/events

• Participants will be prompted to request to join the Novavax, Inc. call.
• To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled webcast.

Replay details:
Date:	Available starting at 11:30 a.m. EST, November 9, 2023, until 11:59 p.m. U.S. EST, November 16, 2023
Dial-in number:	(800) 645-7964 (Domestic) or (757) 849-6722 (International)
Passcode:	5567#
Webcast:	ir.novavax.com/events, until February 7, 2024

About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. Focused on the world's most urgent health challenges, Novavax is currently evaluating vaccines for COVID-19, influenza and COVID-19 and influenza combined. Please visit novavax.com and LinkedIn for more information.

Contacts: 
Investors
Erika Schultz
240-268-2022
ir@novavax.com

Media
Ali Chartan
240-720-7804
media@novavax.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-host-conference-call-to-discuss-third-quarter-2023-financial-results-and-operational-highlights-on-november-9-2023-301974716.html

SOURCE NOVAVAX, INC

FAQ

When will Novavax, Inc. report its Q3 2023 financial results?

Novavax, Inc. will report its Q3 2023 financial results on November 9, 2023.

What time will the report be released?

The report will be released at 8:30 a.m. EST.

Where can I access the conference call?

The conference call can be accessed at ir.novavax.com/events.

What is the dial-in number for the conference call?

The dial-in number for domestic participants is (877) 550-1858, and for international participants is (848) 488-9160.

What is the passcode for the conference call?

The passcode for the conference call is 1754341.

When will the replay be available?

The replay will be available starting at 11:30 a.m. EST on November 9, 2023, until 11:59 p.m. EST on November 16, 2023.

What is the dial-in number for the replay?

The dial-in number for domestic participants is (800) 645-7964, and for international participants is (757) 849-6722.

What is the passcode for the replay?

The passcode for the replay is 5567#.

Until when can I access the webcast replay?

The webcast replay can be accessed until February 7, 2024, at ir.novavax.com/events.